Co-Treatment with the Epigenetic Drug, 3-Deazaneplanocin A (DZNep) and Cisplatin after DZNep Priming Enhances the Response to Platinum-Based Therapy in Chondrosarcomas

por Lhuissier, Eva, Aury-Landas, Juliette, Lenté, Marion, Boumediene, Karim, Baugé, Catherine
Publicado 2021

Heterogeneity of chondrosarcomas response to irradiations with X-rays and carbon ions: A comparative study on five cell lines

por Girard, Nicolas, Lhuissier, Eva, Aury-Landas, Juliette, Cauvard, Olivier, Lente, Marion, Boittin, Martine, Baugé, Catherine, Boumédiene, Karim
Publicado 2020